4-氟-苯甲酰基异氰酸酯 | 18354-35-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟-苯甲酰基异氰酸酯
• 英文名称: 4-fluorobenzoyl isocyanate
• 英文别名: p-Fluorbenzoylisocyanat
• CAS: 18354-35-3
• 化学式: C₈H₄FNO₂
• mdl: MFCD00673066
• 分子量: 165.124
• InChiKey: DBCORYGNTYHQBR-UHFFFAOYSA-N

物化性质

• 密度：
  1.2870

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  46.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2929109000

SDS

Name:	4-Fluorobenzoyl isocyanate Material Safety Data Sheet
Synonym:	None
CAS:	18354-35-3

Section 1 - Chemical Product MSDS Name:4-Fluorobenzoyl isocyanate Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
18354-35-3	4-Fluorobenzoyl isocyanate	100	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
Causes eye irritation. Lachrymator (substance which increases the flow of tears). May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Organic isocyanates can cause local irritation and allergic reactions.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. At high concentrations, isocyanates affect mucous membranes of the respiratory tract and may lead to fatal pulmonary edema. Exposure to low and often even unmeasurable isocyanate concentration results in sensitization. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed. Chronic overexposure to isocyanates has been reported to cause lung damage, including decreased lung fuction, which may be permanent.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Do NOT allow victim to rub eyes or keep eyes closed.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Cool containers with flooding quantities of water until well after fire is out. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 18354-35-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid or liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 48 deg C @ .20 mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 98 deg C ( 208.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.287
Molecular Formula: FC6H4CONCO
Molecular Weight: 165.12

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Ignition sources, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 18354-35-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Fluorobenzoyl isocyanate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: ISOCYANATES, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2206
Packing Group: III
IMO
Shipping Name: ISOCYANATES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 2206
Packing Group: III
RID/ADR
Shipping Name: ISOCYANATES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 2206
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 18354-35-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 18354-35-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 18354-35-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氟-苯甲酰基异氰酸酯 在 2,6-二甲基吡啶 、 四(三苯基膦)钯 、 bis(triphenylylphosphine)palladium(II) dichloride 、 溴 、 sodium carbonate 作用下， 以 乙二醇二甲醚 、 正己烷 、 二氯甲烷 、 氯仿 为溶剂， 反应 1.43h， 生成 5-(2-(4-fluorophenyl)-5-(pyridin-4-yl)oxazol-4-yl)-3-methoxypyridin-2-amine
  参考文献：
  名称：

  Novel Heterocyclic Compounds and Uses Thereof

  摘要：

  提供了新的替代杂环化合物，含有它们的组合物，以及使用它们抑制Raf激酶活性的方法。这些新化合物和组合物可以单独使用，也可以与至少一种额外的药物联合使用，用于治疗由Raf激酶介导的疾病，如癌症。

  公开号：

  US20130210818A1
• 作为产物：
  描述：

  对氟苯甲酸 在 ammonium hydroxide 、 氯化亚砜 作用下， 以 1,2-二氯乙烷 、 甲苯 为溶剂， 反应 10.0h， 生成 4-氟-苯甲酰基异氰酸酯
  参考文献：
  名称：

  N-取代的苯甲酰基-1,2,3,4-四氢喹啉基-1-羧酰胺的设计，合成及杀真菌活性

  摘要：

  为了寻找具有高生物活性的新的铅化合物，采用连接活性亚结构法设计了一系列N-取代的苯甲酰基-1,2,3,4-四氢喹啉基-1-羧酰胺。由取代的苯甲酸按四个步骤合成目标化合物，并通过1 H NMR，IR光谱和元素分析确定其结构。体外生物测定结果表明，某些目标化合物表现出优异的杀真菌活性，且取代基的位置在杀真菌活性中起重要作用。特别是，化合物5n对两种测试真菌Valsa mali和Sclerotionia sclerotiorum的杀真菌活性比市售杀真菌剂氟苯尼更好。，其EC 50值分别为3.44和2.63 mg / L。而且它还显示出良好的针对核盘菌的体内杀真菌活性，其EC 50值为29.52 mg / L。

  DOI：

  10.1016/j.bmcl.2016.03.085

文献信息

• Scalable Synthetic Strategy for Unsymmetrical Trisubstituted <i>s</i>-Triazines
  作者：Helong Liang、Ganzhong Li、Lei Zhang、Gefei Wang、Mingyu Song、Heng Li、Bingxin Yuan

  DOI：10.1021/acs.orglett.1c01970

  日期：2021.8.6

  variety of unsymmetrical trisubstituted 1,3,5-triazines was developed. This protocol applied in situ formed acyl isocyanate from amide to react with amidine, introducing two substituents to the 1,3,5-triazinone ring with a low production cost and a simple workup procedure. The scalability of this method was demonstrated by translating a small-scale procedure to a multi-kilogram-scale synthesis. Chlorination

  开发了一种可扩展的合成策略来生产多种不对称的三取代 1,3,5-三嗪。该方案应用由酰胺原位形成的酰基异氰酸酯与脒反应，以较低的生产成本和简单的后处理程序将两个取代基引入 1,3,5-三嗪酮环。该方法的可扩展性通过将小规模程序转化为数公斤规模的合成来证明。氯化和与各种亲核试剂的进一步偶联反应可以提供带有不同官能团的不对称三取代 1,3,5-三嗪。
• Design, Synthesis, and Insecticidal Activity of Novel Doramectin Derivatives Containing Acylurea and Acylthiourea Based on Hydrogen Bonding
  作者：Qi Zhang、Yao Cheng、Cheng Zheng、Ping Bai、Jian Yang、Xiaoxia Lu

  DOI：10.1021/acs.jafc.0c00230

  日期：2020.5.27

  investigation on the insecticidal activities of several doramectin derivatives preliminarily revealed that the presence of hydrogen bonds at the C4″ position of the molecule with target protein γ-aminobutyric acid (GABA) receptor was crucial for retaining high insecticidal activity. As a continuation of our research work on the development of new insecticides, two series of novel acylurea and acylthiourea

  我们最近对几种多拉菌素衍生物的杀虫活性的研究初步表明，在具有目标蛋白γ-氨基丁酸（GABA）受体的分子的C4''位置存在氢键对于保持高杀虫活性至关重要。作为我们对新型杀虫剂开发的研究工作的继续，设计并合成了两个系列的新型酰基脲和酰基硫脲多拉菌素衍生物。生物测定结果表明，在我们的实验室中，新合成的化合物（5o，5t和6t）对小菜蛾，东方粘虫和玉米bore的杀虫活性高于对照化合物doramectin，市售阿维菌素，敌百虫和铅化合物3g。特别，化合物5t被确定为最有前景的小菜蛾杀虫剂，在低浓度12.50 mg / L时最终死亡率为80.00％，其效力比母体多拉菌素高约7.75倍（LC50值为48.1547 mg / L ），效力比市售阿维菌素（LC50值为40.5507 mg / L）高6.52倍，效力比化合物3g（LC50值为24.7742 mg / L）高3.98倍。此外，分子对接模拟显示化合物5t（2
• Synthesis and anthelmintic activity of 3'-benzoylurea derivatives of 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
  作者：Robert J. Weikert、Stanford Bingham、Mark A. Emanuel、Elizabeth B. Fraser-Smith、David G. Loughhead、Peter H. Nelson、Anthony L. Poulton

  DOI：10.1021/jm00109a015

  日期：1991.5

  Reaction of 3-amino derivatives of the nematocides tetramisole and levamisole with variously substituted benzoylisocyanates gave a series of benzoylureas I which were tested for activity against helminths and ectoparasites. Compounds bearing 2,6-difluoro and 4-trifluoromethyl substituents had potent nematocidal activity in both mice and sheep. No antiectoparasitic activity was observed.

  线虫杀虫剂四咪唑和左旋咪唑的3-氨基衍生物与各种取代的苯甲酰基异氰酸酯的反应产生了一系列苯甲酰脲I，测试了其对蠕虫和体外寄生虫的活性。带有2，6-二氟和4-三氟甲基取代基的化合物在小鼠和绵羊中均具有有效的杀线虫活性。没有观察到抗寄生虫活性。
• 一种芳基甲酰基异氰酸酯的合成方法
  申请人：丽水学院

  公开号：CN108912013A

  公开（公告）日：2018-11-30

  本发明涉及一种制备方法，主要涉及一种芳基甲酰基异氰酸酯的合成方法。一种芳基甲酰基异氰酸酯的合成方法，该方法包括以下步骤：①用有机溶剂溶解的芳基甲酰胺溶液滴加到二（三氯甲基）碳酸酯溶液中；②缓慢升到高温阶60~180℃，并在该反应温度下滴加剩余二（三氯甲基）碳酸酯溶于步骤1的溶液中，0.5~5小时加完，加完继续反应1~6小时，反应完回收有机溶剂，有机溶剂经减压蒸馏液得到所述的芳基甲酰基异氰酸酯；本方法克服了现有技术草酰氯或光气使用的安全性差，投资成本高的问题，新方法的工艺合理，生产环保，成本低，安全可靠；提取芳基甲酰基异氰酸酯收率高，三废少，是适用于工业化生产的方法。
• [EN] hTERT MODULATORS AND METHODS OF USE<br/>[FR] MODULATEURS HTERT ET PROCÉDÉS D'UTILISATION
  申请人：UNIV ARIZONA

  公开号：WO2017095969A1

  公开（公告）日：2017-06-08

  The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula as described herein. Some aspects of the invention are based on the characterization of the effect of hTERT core promoter region mutants on the 5-12 G-quadruplex structure and its stability. It is believed that some of the compounds of the invention bind selectively to the G-quadruplex in the hTERT core promoter mutant, which results in reversal of the effect of mutant promoter activation.

  本发明提供hTERT调节剂及其生产和使用方法。具体来说，本发明提供了如下所述的一种化合物。该发明的一些方面基于对hTERT核心启动子区域突变体对5-12 G-四链结构及其稳定性影响的表征。据信，本发明的一些化合物选择性地结合到hTERT核心启动子突变体中的G-四链结构，从而逆转突变启动子激活的效果。